Market Overview:
The global dexamethasone acetate market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The growth in the market can be attributed to factors such as rising prevalence of chronic diseases, increasing demand for generic drugs and technological advancements in the field of drug delivery systems. However, stringent regulatory norms and high cost associated with R&D are some of the major factors restraining the growth of this market. Based on type, crystal segment is expected to account for a larger share in terms revenue contribution as compared to powder segment during the forecast period. This can be attributed to its growing demand from hospitals and clinics applications across regions. By application, hospitals segment is anticipated to hold a dominant position in terms revenue contribution throughout 2030 owing to rising incidence rates of chronic diseases which require hospitalization for treatment purposes.
Product Definition:
Dexamethasone acetate is a synthetic glucocorticoid corticosteroid with anti-inflammatory and immunosuppressive properties. Dexamethasone acetate is used to treat various inflammatory conditions such as asthma, allergic rhinitis, eczema, and psoriasis. Dexamethasone acetate also has been shown to be effective in the treatment of autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus.
Crystal:
Crystal or Dexamethasone is a synthetic glucocorticoid used to treat Cushing syndrome, multiple sclerosis, and corticosteroid- responsive asthma. Dexamethasone is also given to patients who cannot be treated with other drugs for Cushing’s syndrome and multiple sclerosis. It has no effect on the human fetus when administered systemically at doses greater than those required to maintain hydration levels in maternal blood.
Powder:
Powder is a dry and granular form of medication used in Dexamethasone Acetate. It is usually packaged in blisters or pre-filled syringes. The drug has to be mixed with water, milk or juice before consumption. Dexamethasone powder can also be administered without the need for mixing with fluids as it is highly soluble in alcohol (e.g., ethanol).
Application Insights:
The others segment dominated the global market in terms of revenue share in 2017. This is due to the high usage of glucocorticoids for various indications such as asthma, rheumatoid arthritis, osteoarthritis and other autoimmune diseases. The home care application segment is expected to witness significant growth over the forecast period owing to rising awareness about effective treatment options among consumers.
Glucocorticoids are used for treating a variety of skin conditions including atopic dermatitis (eczema), sebostasis (scaling) and xerosis (dryness). They are also used for topical administration in cases where there has been no response to conventional therapy or when symptoms have relapsed after successful treatment with conventional therapies.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position throughout the forecast period owing to increasing awareness about various treatment options, presence of well-established healthcare facilities, and availability of skilled professionals. Moreover, rising prevalence of skin disorders is anticipated to fuel product demand in this region.
Asia Pacific is estimated to be the fastest-growing regional market from 2018 to 2030 due for instance increased penetration of generic drugs and growing medical tourism industry in countries such as India & China & Malaysia etc.; which will drive demand for dexamethasone acetate tablets over next eight years. In addition DexaMed has a distribution agreement with Takeda Pharmaceuticals Australia Pty Ltd., so it will help company get access into Australian market much easier; however there are no information regarding launch date yet but it should be soon since product has already passed all required regulatory processes including approval by Therapeutic Goods Administration (TGA).
Growth Factors:
- Increasing prevalence of chronic diseases such as asthma, arthritis, and cancer is expected to drive the demand for dexamethasone acetate in the coming years.
- The increasing use of dexamethasone acetate in various medical applications is another key factor that is expected to fuel market growth over the forecast period.
- Rising awareness about the benefits of dexamethasone acetate among consumers is anticipated to boost market growth over the next few years.
- The increasing number of research and development activities for new applications of dexamethasone acetate is projected to create lucrative opportunities for market players in the near future.
Scope Of The Report
Report Attributes
Report Details
Report Title
Dexamethasone Acetate Market Research Report
By Type
Crystal, Powder
By Application
Hospitals, Clinics, Home Care, Others
By Companies
Chemocare, Sigma-Aldrich, Kingyork, LGM Pharma, Tianjin Jinjin Pharmaceutical, Alfa Aesar, Kumaka Industries, Evaluate, Treato, BTP Pharm, Chemocare
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
225
Number of Tables & Figures
158
Customization Available
Yes, the report can be customized as per your need.
Global Dexamethasone Acetate Market Report Segments:
The global Dexamethasone Acetate market is segmented on the basis of:
Types
Crystal, Powder
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Home Care, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Chemocare
- Sigma-Aldrich
- Kingyork
- LGM Pharma
- Tianjin Jinjin Pharmaceutical
- Alfa Aesar
- Kumaka Industries
- Evaluate
- Treato
- BTP Pharm
- Chemocare
Highlights of The Dexamethasone Acetate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Crystal
- Powder
- By Application:
- Hospitals
- Clinics
- Home Care
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Dexamethasone Acetate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Dexamethasone acetate is a corticosteroid medication that is used to treat various conditions, including asthma, eczema, and psoriasis. It works by reducing inflammation and swelling in the body.
Some of the major companies in the dexamethasone acetate market are Chemocare, Sigma-Aldrich, Kingyork, LGM Pharma, Tianjin Jinjin Pharmaceutical, Alfa Aesar, Kumaka Industries, Evaluate, Treato, BTP Pharm, Chemocare.
The dexamethasone acetate market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Dexamethasone Acetate Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Dexamethasone Acetate Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Dexamethasone Acetate Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Dexamethasone Acetate Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Dexamethasone Acetate Market Size & Forecast, 2018-2028
4.5.1 Dexamethasone Acetate Market Size and Y-o-Y Growth
4.5.2 Dexamethasone Acetate Market Absolute $ Opportunity
Chapter 5 Global Dexamethasone Acetate Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Dexamethasone Acetate Market Size Forecast by Type
5.2.1 Crystal
5.2.2 Powder
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Dexamethasone Acetate Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Dexamethasone Acetate Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Home Care
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Dexamethasone Acetate Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Dexamethasone Acetate Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Dexamethasone Acetate Analysis and Forecast
9.1 Introduction
9.2 North America Dexamethasone Acetate Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Dexamethasone Acetate Market Size Forecast by Type
9.6.1 Crystal
9.6.2 Powder
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Dexamethasone Acetate Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Home Care
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Dexamethasone Acetate Analysis and Forecast
10.1 Introduction
10.2 Europe Dexamethasone Acetate Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Dexamethasone Acetate Market Size Forecast by Type
10.6.1 Crystal
10.6.2 Powder
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Dexamethasone Acetate Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Home Care
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Dexamethasone Acetate Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Dexamethasone Acetate Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Dexamethasone Acetate Market Size Forecast by Type
11.6.1 Crystal
11.6.2 Powder
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Dexamethasone Acetate Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Home Care
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Dexamethasone Acetate Analysis and Forecast
12.1 Introduction
12.2 Latin America Dexamethasone Acetate Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Dexamethasone Acetate Market Size Forecast by Type
12.6.1 Crystal
12.6.2 Powder
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Dexamethasone Acetate Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Home Care
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Dexamethasone Acetate Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Dexamethasone Acetate Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Dexamethasone Acetate Market Size Forecast by Type
13.6.1 Crystal
13.6.2 Powder
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Dexamethasone Acetate Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Home Care
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Dexamethasone Acetate Market: Competitive Dashboard
14.2 Global Dexamethasone Acetate Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Chemocare
14.3.2 Sigma-Aldrich
14.3.3 Kingyork
14.3.4 LGM Pharma
14.3.5 Tianjin Jinjin Pharmaceutical
14.3.6 Alfa Aesar
14.3.7 Kumaka Industries
14.3.8 Evaluate
14.3.9 Treato
14.3.10 BTP Pharm
14.3.11 Chemocare
